SCHEMBL6903955

SCHEMBL6903955

Cc1cccc(Cl)c1NC(=O)c1ccc2nc(NC(=O)Oc3ccccc3)sc2c1

nearest known ligand 0.75

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.75
FYN P06241 1/20 0.68
SRC P12931 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6058279 0.88 LCK (0.81) LCKFYNSRC
SCHEMBL6057632 0.87 LCK (0.72) LCK
SCHEMBL6058247 0.84 LCK (0.73) LCKFYNSRC
SCHEMBL6057930 0.83 LCK (0.80) LCKFYNSRC
SCHEMBL6058083 0.83 LCK (1.00) LCKFYNSRC
SCHEMBL6058145 0.83 LCK (0.86) LCKFYNSRC
SCHEMBL6057783 0.83 LCK (0.72) LCKFYNSRC
SCHEMBL6058072 0.82 LCK (0.75) LCKFYNSRC
SCHEMBL6057876 0.82 LCK (0.85) LCKFYNSRC
SCHEMBL6057847 0.82 LCK (0.81) LCKFYNSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825355-B2 FOR THERAPY OF IMMUNOLOGIC DISORDERS SUCH AS TRANSPLANT REJECTION, RHEUMATOID ARTHRITIS. MULTIPLE SCLEROSIS, INFLAMMATORY BOWEL DISEASE, LUPUS, GRAFT VS. HOST DISEASE BRISTOL-MYERS SQUIBB CO. 2004-11-30 US disclosed